Calithera Biosciences (NASDAQ:CALA) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALAFree Report) in a research note released on Monday. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Up 60.0 %

Shares of NASDAQ CALA opened at $0.02 on Monday. Calithera Biosciences has a fifty-two week low of $0.01 and a fifty-two week high of $0.50. The company has a 50 day simple moving average of $0.02 and a two-hundred day simple moving average of $0.03.

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Read More

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.